US Supreme Court Rules on DNA Patents

A long debate comes to an end today as the US Supreme Court upends patentability of genes! The supreme court decision opens opportunities for BRCA testing by Next Generation Sequencing, but how you find those long indels? This is where we help! Here is how our method was checked...

 

Read more

Omixon and Knome partner to offer advanced HLA typing for whole genome!

We have great news today as Omixon Biocomputing and Knome has become partners to offer advanced HLA typing for whole genome and exome level data. We believe that this partnership will help us “discover safer and more efficient therapies by identifying genomic biomarkers for drug response and adverse response,”...

 

Read more

Omixon is attending TCGC in San Francisco. Meet us there!

The Clinical Genome Conference (TCGC) 2013 brings together many constituencies for frank and vital discussion of the applications, questions and solutions surrounding clinical genome analysis, including scientists, physicians, diagnosticians, genetic counselors, bioinformaticists, ethicists, regulators, insurers, lawyers, and administrators. Omixon is exhibiting at TCGC in San Francisco, from 25th to...

 

Read more

Omixon at ESHG in Paris

Omixon is going to exhibit at the annual meeting of the European Society for Human Genetics in Paris, France, 8-11 June 2013. The conference will cover all aspects of human genetics, from the cutting edge of research into the human genome and individual genetic or chromosomal conditions, right through...

 

Read more

Omixon at EFI conference in Maastricht

Omixon is presenting and exhbiting at EFI European Immunogenetics and Histocompatibility Conference in Maastricht, The Netherlands,  11-14th May. Our CEO, Attila Berces is going to present our technology and solution for experts working in medical fields related to HLA.

 

Read more